Home / Inspections / 1258104

FDA Inspection 1258104 — Grifols Diagnostic Solutions, Inc.

Grifols Diagnostic Solutions, Inc. — FEI 1000124057

The FDA completed an inspection of Grifols Diagnostic Solutions, Inc. on December 13, 2024 in Emeryville, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 13, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Emeryville, CA (United States)

Facility

Other inspections at this facility

  • 1289592 (VAI Fri Oct 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1162064 (NAI Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079880 (VAI Fri Feb 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 991586 (VAI Wed Sep 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 894326 (NAI Wed Jan 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources